PAPER Chipika RH, Siah WF, Shing SL, Finegan E, McKenna MC, Christidi F, Chang KM, Karavasilis E, Vajda A, Hengeveld JC, Doherty MA, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, Bede P

MRI data confirm the selective involvement of thalamic and amygdalar nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.

Data Brief. 2020 Oct;32:106246. Epub 2020 Sep 1 PubMed: 32944601

PAPER Beers DR, Zhao W, Neal DW, Thonhoff JR, Thome AD, Faridar A, Wen S, Wang J, Appel SH

Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis.

Sci Rep. 2020 Sep 17;10(1):15295. PubMed: 32943739

PAPER Forsberg Morén A, Varrone A

Timing is everything: tau imaging across stages of Alzheimer's disease.

Brain. 2020 Sep 1;143(9):2634-2636. PubMed: 32947616

PAPER Zhao A, Li Y, Deng Y, Alzheimer’s Disease Neuroimaging Initiative

TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.

Neurosci Lett. 2020 Nov 1;738:135392. Epub 2020 Sep 15 PubMed: 32947003

PAPER Francesco DL, Koch G

Synaptic impairment: The new battlefield of Alzheimer's disease.

Alzheimers Dement. 2021 Feb;17(2):314-315. Epub 2020 Sep 18 PubMed: 32946657

PAPER Huang Y, Jianfang M, Morales R, Tang H

Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype.

Prion. 2020 Dec;14(1):232-237. PubMed: 32946318

PAPER Quan Q, Li X, Feng J, Hou J, Li M, Zhang B

Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.

Mol Med Rep. 2020 Oct;22(4):3277-3288. Epub 2020 Aug 7 PubMed: 32945455

PAPER Pedroso RV, Fraga FJ, Pavarini SC, Nascimento CM, Ayán C, Cominetti MR

A Systematic Review of Altered P300 Event-Related Potential in Apolipoprotein E4 (APOE4) Carriers.

Clin EEG Neurosci. 2020 Sep 18;:1550059420959966. PubMed: 32945192

PAPER Lao PJ, Gutierrez J, Keator D, Rizvi B, Banerjee A, Igwe KC, Laing KK, Sathishkumar M, Moni F, Andrews H, Krinsky-McHale S, Head E, Lee JH, Lai F, Yassa MA, Rosas HD, Silverman W, Lott IT, Schupf N, Brickman AM

Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Ann Neurol. 2020 Dec;88(6):1165-1177. Epub 2020 Oct 9 PubMed: 32944999

PAPER Huang C, Wen C, Yang M, Li A, Fan C, Gan D, Li Q, Zhao J, Zhu L, Lu D

Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR.

J Neuroimmune Pharmacol. 2020 Sep 18; PubMed: 32944864

PAPER Chen YY, Wang MC, Wang YN, Hu HH, Liu QQ, Liu HJ, Zhao YY

Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy.

Biomark Res. 2020;8:42. Epub 2020 Sep 11 PubMed: 32944245

PAPER Chidambaram H, Das R, Chinnathambi S

Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation.

Cell Biosci. 2020;10:109. Epub 2020 Sep 15 PubMed: 32944223

PAPER Gabr M, Rehman AU, Chen HF

Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

ACS Med Chem Lett. 2020 Sep 10;11(9):1759-1765. Epub 2020 Aug 11 PubMed: 32944144

PAPER Schrauf RW

Epistemic Responsibility- Labored, Loosened, and Lost: Staging Alzheimer's Disease.

J Pragmat. 2020 Oct;168:56-68. Epub 2020 Aug 1 PubMed: 32943809

PAPER Villoslada P, Baeza-Yates R, Masdeu JC

Author Correction: Reclassifying neurodegenerative diseases.

Nat Biomed Eng. 2020 Dec;4(12):1221. PubMed: 32943770